Table 2 Statistical analysis of anticancer activity of te-AgNPs, gr-AgNPs and am-AgNPs by Analysis of Variance (ANOVA).
Source of variation | Df | Sum of squares | Mean squares | F Values | P value | Fcrit |
|---|---|---|---|---|---|---|
Antimicrobial analysis | ||||||
Rows | 5 | 68.50938 | 68.50938 | 4.913635 | 0.001646 | 2.485143 |
Columns | 7 | 1745.305 | 1745.305 | 89.41206 | 2E − 20 | 2.285235 |
Anticancer analysis | ||||||
MTT assay | ||||||
Rows | 5 | 9334.055 | 1866.811 | 222.5921 | 6.5E − 10 | 3.325835 |
Columns | 2 | 91.53243 | 45.76622 | 5.457006 | 0.024993 | 4.102821 |
XTT assay | ||||||
Rows | 5 | 6469.263 | 1293.853 | 201.3545 | 1.07E − 09 | 3.325835 |
Columns | 2 | 70.94941 | 35.47471 | 5.520714 | 0.024245 | 4.102821 |
SRB assay | ||||||
Rows | 56932.403 | 6932.403 | 1386.481 | 258.9191 | 3.07E − 10 | 3.325835 |
Columns | 260.96168 | 60.96168 | 30.48084 | 5.692162 | 0.022363 | 4.102821 |
IC50 | ||||||
Sample | te-AgNPS | am-AgNPs | gr-AGNPs | |||
IC50 | 18.04 ± 0.63 | 14.77 ± 0.89 | 15.42 ± 0.37 | |||
Rows | 2 | 2.145225 | 1.072613 | 8.382651 | 0.037106 | 6.944272 |
Columns | 2 | 17.92585 | 8.962922 | 70.04676 | 0.000771 | 6.944272 |
